Gilder Gagnon Howe & Co’s NuVasive, Inc. NUVA Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-22,666	Closed	-$1.26M	–	310
2017 Q3	$1.26M	Sell	22,666 -5,377	-19%	-$356K	0.02%	198
2017 Q2	$2.16M	Sell	28,043 -820	-3%	-$61.3K	0.03%	177
2017 Q1	$2.15M	Sell	28,863 -1,384	-5%	-$100K	0.04%	169
2016 Q4	$2.04M	Sell	30,247 -334	-1%	-$21.5K	0.04%	160
2016 Q3	$2.04M	Sell	30,581 -47	-0.2%	-$2.99K	0.04%	167
2016 Q2	$1.83M	Buy	+30,628	New	+$1.66M	0.04%	167

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Gilder Gagnon Howe & Co's NUVA Position: Q4 2017 in Review

Gilder Gagnon Howe & Co sold out of NuVasive, Inc. (NUVA) in Q4 2017, closing a stake of 22,666 shares — an estimated $1.26M sold.

Gilder Gagnon Howe & Co first reported a position in NUVA in Q2 2016 and held it in 6 quarters. The position peaked at $2.16M in Q2 2017. 269 funds tracked by Wall St. Rank hold NUVA as of Q4 2017.

Gilder Gagnon Howe & Co reported no remaining NuVasive, Inc. position as of Q4 2017 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 22,666 NuVasive, Inc. shares in Q4 2017, an estimated $1.26M.
Gilder Gagnon Howe & Co first reported a position in NuVasive, Inc. in Q2 2016 and held it in 6 quarters.
Gilder Gagnon Howe & Co's NuVasive, Inc. position peaked at $2.16M in Q2 2017.
269 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2017.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2017, filed 31 Jan 2018.